Immunity, Inflammation, and Cancer

被引:8375
作者
Grivennikov, Sergei I. [1 ,2 ]
Greten, Florian R. [3 ]
Karin, Michael [1 ,2 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Dept Pathol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA
[3] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-81675 Munich, Germany
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; PROMOTE TUMOR-GROWTH; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; EPITHELIAL-MESENCHYMAL TRANSITION; CHRONIC LYMPHOCYTIC-LEUKEMIA; COLITIS-ASSOCIATED CANCER; NECROSIS-FACTOR-ALPHA; T-CELL RESPONSES; MYELOID CELLS; TGF-BETA;
D O I
10.1016/j.cell.2010.01.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inflammatory responses play decisive roles at different stages of tumor development, including initiation, promotion, malignant conversion, invasion, and metastasis. Inflammation also affects immune surveillance and responses to therapy. Immune cells that infiltrate tumors engage in an extensive and dynamic crosstalk with cancer cells, and some of the molecular events that mediate this dialog have been revealed. This review outlines the principal mechanisms that govern the effects of inflammation and immunity on tumor development and discusses attractive new targets for cancer therapy and prevention.
引用
收藏
页码:883 / 899
页数:17
相关论文
共 155 条
[1]   Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe [J].
Aggarwal, Bharat B. ;
Vijayalekshmi, R. V. ;
Sung, Bokyung .
CLINICAL CANCER RESEARCH, 2009, 15 (02) :425-430
[2]   B-cell-derived lymphotoxin promotes castration-resistant prostate cancer [J].
Ammirante, Massimo ;
Luo, Jun-Li ;
Grivennikov, Sergei ;
Nedospasov, Sergei ;
Karin, Michael .
NATURE, 2010, 464 (7286) :302-U187
[3]   FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis [J].
Andreu, Pauline ;
Johansson, Magnus ;
Affara, Nesrine I. ;
Pucci, Ferdinando ;
Tan, Tingting ;
Junankar, Simon ;
Korets, Lidiya ;
Lam, Julia ;
Tawfik, David ;
DeNardo, David G. ;
Naldini, Luigi ;
de Visser, Karin E. ;
De Palma, Michele ;
Coussens, Lisa M. .
CANCER CELL, 2010, 17 (02) :121-134
[4]   PHORBOL ESTER INDUCIBLE GENES CONTAIN A COMMON CIS ELEMENT RECOGNIZED BY A TPA-MODULATED TRANS-ACTING FACTOR [J].
ANGEL, P ;
IMAGAWA, M ;
CHIU, R ;
STEIN, B ;
IMBRA, RJ ;
RAHMSDORF, HJ ;
JONAT, C ;
HERRLICH, P ;
KARIN, M .
CELL, 1987, 49 (06) :729-739
[5]   The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Criollo, Alfredo ;
Ortiz, Carla ;
Lidereau, Rosette ;
Mariette, Christophe ;
Chaput, Nathalie ;
Mira, Jean-Paul ;
Delaloge, Suzette ;
Andre, Fabrice ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
IMMUNOLOGICAL REVIEWS, 2007, 220 :47-59
[6]   Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Obeid, Michel ;
Ortiz, Carla ;
Criollo, Alfredo ;
Mignot, Gregoire ;
Maiuri, M. Chiara ;
Ullrich, Evelyn ;
Saulnier, Patrick ;
Yang, Huan ;
Amigorena, Sebastian ;
Ryffel, Bernard ;
Barrat, Franck J. ;
Saftig, Paul ;
Levi, Francis ;
Lidereau, Rosette ;
Nogues, Catherine ;
Mira, Jean-Paul ;
Chompret, Agnes ;
Joulin, Virginie ;
Clavel-Chapelon, Francoise ;
Bourhis, Jean ;
Andre, Fabrice ;
Delaloge, Suzette ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
NATURE MEDICINE, 2007, 13 (09) :1050-1059
[7]   Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development [J].
Aspord, Caroline ;
Pedroza-Gonzalez, Alexander ;
Gallegos, Mike ;
Tindle, Sasha ;
Burton, Elizabeth C. ;
Su, Dan ;
Marches, Florentina ;
Banchereau, Jacques ;
Palucka, A. Karolina .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (05) :1037-1047
[8]   Tumour necrosis factor and cancer [J].
Balkwill, Frances .
NATURE REVIEWS CANCER, 2009, 9 (05) :361-371
[9]   TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling [J].
Becker, C ;
Fantini, MC ;
Schramm, C ;
Lehr, HA ;
Wirtz, S ;
Nikolaev, A ;
Burg, J ;
Strand, S ;
Kiesslich, R ;
Huber, S ;
Ito, H ;
Nishimoto, N ;
Yoshizaki, K ;
Nishimoto, N ;
Galle, PR ;
Blessing, M ;
Rose-John, S ;
Neurath, MF .
IMMUNITY, 2004, 21 (04) :491-501
[10]   Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses [J].
Berg, DJ ;
Davidson, N ;
Kuhn, R ;
Muller, W ;
Menon, S ;
Holland, G ;
ThompsonSnipes, L ;
Leach, MW ;
Rennick, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1010-1020